We’ve put together a glossary of common technical terms and phrases.
Term |
Definition |
Biomarker |
A biological substance or chemical that indicates the presence of a disease. |
Biopsy |
A tissue sample taken from a body organ and analyzed, usually under a microscope, to confirm disease diagnosis. |
Carcinoma |
A form of cancer that tends to spread. |
CIS |
Carcinoma in situ. Flat, superficial bladder tumors that tend to grow rapidly and recur. |
Clinical trial |
A scientific study of a drug or procedure in patients with a specific condition. Results from clinical trials are typically reviewed by medical experts and published in scientific journals. |
Cystoscopy |
Placement of a thin, flexible tube and camera inside the urine tube (urethra) and bladder. |
DNA |
Deoxyribonucleic acid. The molecule is a double helix made up of four bases: adenine, cytosine, guanine, thymine. It carries the genetic ‘code’ for the body. |
Dysuria |
Painful ‘peeing’ (urination). |
Gene |
A section of DNA that controls the growth and function of body cells. |
HCP |
Healthcare professional. |
Hematuria |
Blood in the urine. |
Invasive bladder cancer |
Cancer that spreads from the bladder lining (urothelium) to deeper layers of the bladder wall. |
Macrohematuria |
Blood in the urine (visible). |
Microhematuria |
Blood in the urine (invisible). |
Molecular diagnostic test |
A test used to identify a disease based on genetic information. |
Monitoring |
Watching patients for disease worsening or disease return (recurrence). |
mRNA |
Messenger ribonucleic acid. This is similar to DNA. It uses the genetic ‘code’ to direct protein production inside the body. |
Negative predictive value |
Proportion of individuals with a negative test result who are correctly diagnosed. |
Positive predictive value |
Proportion of individuals with a positive test result who are correctly diagnosed. |
Prognosis |
Prediction of how a patient’s disease will progress. |
Recurrence |
The return of disease after medical treatment. |
RT-qPCR |
Reverse transcription-quantitative polymerase chain reaction. A method for multiplying DNA segments, ready for analysis, in a test tube. |
Sensitivity |
The ability of a test to accurately detect a disease. |
Specificity |
The ability of a test to exclude a disease if it is not actually present. |
Superficial bladder cancer |
Cancer affecting the bladder lining (urothelium) only. |
Tumor |
A mass of extra tissue caused by unusual cell division. |
Ureter |
The urine tube connecting the kidneys to the bladder. |
Urethra |
The urine tube connecting the bladder to the outside of the body. |
Urinary tract |
The entire urinary system (kidneys, ureter, bladder, urethra). |
Urine-sampling system |
A complete Cxbladder system to collect and store your urine sample ready for sending to a Pacific Edge laboratory. |
Urologist |
A specialist doctor who treats diseases of the urinary tract and related conditions. |
Urothelium |
The urine-proof lining along the inside of the urinary tract. |
Validation study |
A clinical trial that confirms the accuracy, reliability and efficiency of a test. |
Last Updated: 18 Oct 2023 11:39 am
Browse Our Latest Blog Articles
-
Talk to your doctor
Are you alarmed about blood in your urine? Worried about bladder cancer? Download our patient discussion guide for a list of questions you can ask your doctor.
Download discussion guide now -
Get Cxbladder
Contact us by phone or email, or fill out an online form and a Cxbladder representative will get back to you.
Complete an information request form today